112 related articles for article (PubMed ID: 29442000)
21. Inhibition of NOTCH3 signalling significantly enhances sensitivity to cisplatin in EBV-associated nasopharyngeal carcinoma.
Man CH; Wei-Man Lun S; Wai-Ying Hui J; To KF; Choy KW; Wing-Hung Chan A; Chow C; Tin-Yun Chung G; Tsao SW; Tak-Chun Yip T; Busson P; Lo KW
J Pathol; 2012 Feb; 226(3):471-81. PubMed ID: 22009689
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
24. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma.
Liu X; Chen L; Feng B; Liu G
Anat Rec (Hoboken); 2014 Feb; 297(2):215-21. PubMed ID: 24376145
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of CXCR4 mediated chemoresistance in nasopharyngeal carcinoma cell line CNE2].
Song XY; Shang XL; Zhang YT; Lin YT; Xu GG; Xue G; Zhang QJ; Zou F
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jun; 30(11):887-891;896. PubMed ID: 29797935
[No Abstract] [Full Text] [Related]
26. BEX3 contributes to cisplatin chemoresistance in nasopharyngeal carcinoma.
Gao W; Li JZ; Chen SQ; Chu CY; Chan JY; Wong TS
Cancer Med; 2017 Feb; 6(2):439-451. PubMed ID: 28083995
[TBL] [Abstract][Full Text] [Related]
27. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhou ZY; Yang JY; Shao CZ; Luo F; Du W
World J Surg Oncol; 2022 Mar; 20(1):88. PubMed ID: 35303867
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
[TBL] [Abstract][Full Text] [Related]
29. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
Zhu X; Li D; Yu F; Jia C; Xie J; Ma Y; Fan S; Cai H; Luo Q; Lv Z; Fan L
Oncotarget; 2016 Mar; 7(11):13139-52. PubMed ID: 26909612
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1.
Dou C; Wang Y; Li C; Liu Z; Jia Y; Li Q; Yang W; Yao Y; Liu Q; Tu K
Oncotarget; 2015 May; 6(15):13216-28. PubMed ID: 25965836
[TBL] [Abstract][Full Text] [Related]
31. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
Zhao Y; Zhang J; Tian Y; Xue C; Hu Z; Zhang L
Drug Des Devel Ther; 2015; 9():4897-907. PubMed ID: 26345996
[TBL] [Abstract][Full Text] [Related]
32. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.
Zhang JX; Qian D; Wang FW; Liao DZ; Wei JH; Tong ZT; Fu J; Huang XX; Liao YJ; Deng HX; Zeng YX; Xie D; Mai SJ
Cancer Lett; 2013 Feb; 329(1):91-8. PubMed ID: 23142283
[TBL] [Abstract][Full Text] [Related]
34. miR-381 overcomes cisplatin resistance in breast cancer by targeting MDR1.
Yi D; Xu L; Wang R; Lu X; Sang J
Cell Biol Int; 2019 Jan; 43(1):12-21. PubMed ID: 30444043
[TBL] [Abstract][Full Text] [Related]
35. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
[TBL] [Abstract][Full Text] [Related]
36. miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.
Jiang Q; Zhang Y; Zhao M; Li Q; Chen R; Long X; Fang W; Liu Z
Tumour Biol; 2016 Feb; 37(2):2425-33. PubMed ID: 26383521
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9.
Dong Z; Zhong Z; Yang L; Wang S; Gong Z
Cancer Lett; 2014 Feb; 343(2):249-57. PubMed ID: 24099915
[TBL] [Abstract][Full Text] [Related]
38. High COX-2 expression contributes to a poor prognosis through the inhibition of chemotherapy-induced senescence in nasopharyngeal carcinoma.
Shi C; Guan Y; Zeng L; Liu G; Zhu Y; Xu H; Lu Y; Liu J; Guo J; Feng X; Zhao X; Jiang W; Li G; Li G; Dai Y; Jin F; Li W; Zhou W
Int J Oncol; 2018 Sep; 53(3):1138-1148. PubMed ID: 29956730
[TBL] [Abstract][Full Text] [Related]
39. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells.
Zhao Z; Zhang L; Yao Q; Tao Z
Cancer Gene Ther; 2015 Apr; 22(3):108-14. PubMed ID: 25721211
[TBL] [Abstract][Full Text] [Related]
40. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
Chen J; Liu S; Li Q; Peng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
